A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI

References

• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:9–25
   PubMedGoogle Scholar
• Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:162–8
   PubMed Web of Science ®Google Scholar
• Targher G, Solagna E, Tosi F, et al. Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. J Endocrinol Invest 2009;32:695–700
   PubMedGoogle Scholar
• Van der Steeg JW, Steures P, Eijkemans MJ, et al. Collaborative Effort for Clinical Evaluation in Reproductive Medicine Study Group. Predictive value of pregnancy history in subfertile couples: results from a nation wide cohort study in the Netherlands. Fertil Steril 2008;90:521–7
   PubMed Web of Science ®Google Scholar
• Brewer C, Balen A. The adverse effects of obesity on conception and implantation. Reproduction 2010;140:347–64
   PubMed Web of Science ®Google Scholar
• Ciepiela P, Baczkowski T, Brelik P, et al. Biotechnological and clinical outcome of in vitro fertilization in non-obese patients with polycystic ovarian syndrome. Folia Histochem Cytobiol 2007;45:S65–71
   PubMedGoogle Scholar
• Haghighi Z, Rezaei Z, Es-Haghi Ashtiani S. Effects of women’s body mass index on in vitro fertilization success: a retrospective cohort study. Gynecol Endocrinol 2012;28:536–9
   PubMed Web of Science ®Google Scholar
• Styne-Gross A, Elkind-Hirsch K, Scott RT. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril 2005;83:1629–34
   PubMed Web of Science ®Google Scholar
• Dechaud H, Anahory T, Reyftmann L, et al. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 2006;127:88–93
   PubMed Web of Science ®Google Scholar
• Matalliotakis I, Cakmak H, Sakkas D, et al. Impact of body mass index on IVF and ICSI outcome: a retrospective study. Reprod Biomed Online 2008;16:778–83
   PubMed Web of Science ®Google Scholar
• Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000;321:1320–1
   PubMed Web of Science ®Google Scholar
• Fedorcsak P, Storeng R, Dale PO, et al. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000;79:43–8
   PubMed Web of Science ®Google Scholar
• Fedorcsak P, Dale PO, Storeng R, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523–8
   PubMed Web of Science ®Google Scholar
• Veleva Z, Tiitinen A, Vilska S, et al. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod 2008;23:878–84
   Google Scholar
• Robker RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology 2008;15:115–21
   PubMedGoogle Scholar
• Orvieto R, Meltcer S, Homburg R, et al. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization? Fertil Steril 2009;91:1466–8
   PubMed Web of Science ®Google Scholar
• Marci R, Lisi F, Soave I, et al. Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist. Gynecol Endocrinol 2012;10:792–5
   Google Scholar
• Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249–61
   PubMed Web of Science ®Google Scholar
• Billig H, Furuta I, Hsueh AJW. Estrogen inhibits and androgen enhances ovarian granulosa cell apoptosis. Endocrinology 1993;133:2204–12
   PubMed Web of Science ®Google Scholar
• Tesarik J, Mendoza C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995;80:1438–43
   PubMed Web of Science ®Google Scholar
• Kurzawa R, Ciepiela P, Baczkowski T, et al. Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study. J Assist Reprod Genet 2008;25:365–74
   PubMed Web of Science ®Google Scholar
• Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013;14:95–109
   PubMed Web of Science ®Google Scholar
• Chun SY, Billig H, Tilly JL, et al. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous IGF-I. Endocrinology 1994;135:1845–53
   PubMed Web of Science ®Google Scholar
• Walters KA, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod 2008;78:380–9
   PubMed Web of Science ®Google Scholar
• Falck S. Site of the production of estrogen in rat ovary as studies in micro-transplants [PhD thesis]. Sweden: University of Lund; 1959
   Google Scholar
• Flemming R, Iloyd F, Herbert M, et al. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follilicular activity, oocyte and embryo function in cycles stimulation with purified follicle stimulation hormone. Hum Reprod 1998;13:1788–92
   PubMedGoogle Scholar
• Flemming R, Rehka P, Deshpande N, et al. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary purified urinary FSH and recombinant FSH. Hum Reprod 2000;15:1440–5
   PubMedGoogle Scholar
• Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002;77:1170–7
   PubMed Web of Science ®Google Scholar
• Al-Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381–8
   PubMed Web of Science ®Google Scholar
• Huang CC, Lien YR, Chen HF, et al. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles. Hum Reprod 2012;27:2036–45
   PubMed Web of Science ®Google Scholar